Human Papilloma Virus
Pathogen Challenge
Keywords:
Human Papilloma Virus, HPV VaccineAbstract
Abstract
Purpose. A review of the history and discovery of the human papiloma virus, was conducted along with the development and difficulities of distribution of the vaccine.
Method. Articles from PubMed, CDC, and FDA were reviewed.
Results. Reading from the journals show a long duration of time from when the disease was initially introduced, to recognition and finally development of a vaccine.
Conclusion. Despite acknowledgement that the vaccine has the pontial to reduce or even rid the disease and so reduce the number of cancers originating from the virus, there are still groups who feel the vaccine has no place in their society.
References
References
Cervical cancer. https://www.who.int/westernpacific/health-topics/cervical-cancer. Accessed Oct 29, 2020.
A brief history of cervical cancer. https://www.globalwomenshealthtechnologies.com/post/2016/12/01/a-brief-history-of-cervical-cancer. Updated 2016. Accessed Oct 29, 2020.
The nobel prize in physiology or medicine 2008. https://www.nobelprize.org/prizes/medicine/2008/hausen/biographical/. Accessed Oct 29, 2020.
Suzich JA, Ghim SJ, Palmer-Hill FJ, et al. Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas. PNAS. 1995;92(25):11553-11557. Accessed Oct 29, 2020.
Gardasil (human papillomavirus quadrivalent (types 6, 11, 16, and 18) vaccine, recombinant) FDA approval history. https://www.drugs.com/history/gardasil.html. Accessed Oct 29, 2020.
What everyone should know | human papillomavirus (HPV) vaccination | vaccination and immunization | CDC. https://www.cdc.gov/vaccines/vpd/hpv/public/index.html. Updated 2020. Accessed Oct 29, 2020.
Nour NM. Cervical cancer: A preventable death. Reviews in obstetrics and gynecology. 2009;2(4):240-244. https://www.ncbi.nlm.nih.gov/pubmed/20111660.
Gilkey MB, Calo WA, Marciniak MW, Brewer NT. Parents who refuse or delay HPV vaccine: Differences in vaccination behavior, beliefs, and clinical communication preferences. Human Vaccines & Immunotherapeutics. 2017;13(3):680-686. https://doi.org/10.1080/21645515.2016.1247134. Accessed Nov 1, 2020.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Pat Stringfellow
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors published in the Journal of Canada's Physician Assistants (JCanPA) retain copyright of their articles, including all drafts and final published version. By agreeing to publish in JCanPA, authors grant the journal the right of first publication and distribution rights of the articles. Authors are free to submit their work to other publications in addition to JCanPA, provided they acknowledge its initial publication in JCanPA.
JCanPA is published online in the public domain. JCanPA holds no legal responsibility as to how these materials are used by the public. Please ensure all authors, co-authors, and investigators have read and agree to these terms.
